Additional Details

  • Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

    Sec Clinical Research - East - Dothan - Graceland /ID# 278328
    Dothan AL. 36305
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    QEII Health Sciences Centre
    Halifax NS. B3H 3A7
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    University of Michigan
    Ann Arbor MI. 48109
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    Vanderbilt University Medical Center
    Nashville TN. 37204
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    McGill University Health Centre (MUHC)
    Montreal QC. H4A 3J1
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    Clinical Research Specialists LLC - Kissimmee
    Kissimmee FL. 34746
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    Virginia Commonwealth University
    Richmond VA. 23298
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    University of Colorado Denver
    Aurora CO. 80045
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    St. Joseph's Healthcare Hamilton
    Hamilton ON. L8N 4A6
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    University of Minnesota
    Minneapolis MN. 55455
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    University of California Los Angeles
    Los Angeles CA. 90095
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    Baylor College of Medicine
    Houston TX. 77030
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    University of Kansas Medical Center
    Kansas City KS. 66160
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    University of Pennsylvania
    Philadelphia PA. 19104
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    Medical University of South Carolina
    Charleston SC. 29425
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    Weill Cornell Medicine-New York-60569
    New York NY. 10021
    View Details
  • A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

    Brigham and Women's Hospital
    Boston MA. 02115
    View Details
  • AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

    CIC Mauricie
    Trois-Rivières QC. G8T 7A1
    View Details
  • AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

    Dynamic Drug Advancement
    Ajax ON. L1S2J5
    View Details
  • A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

    Temple University
    Philadelphia PA. 19140
    View Details